Medicare Enrolled
Dr. George Dakwar, M.D.
Urology Physician · Media, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dakwar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dakwar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dakwar
Dr. George Dakwar is an urology physician in Media, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Dakwar performed 13,689 Medicare services across 3,547 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dakwar received a total of $34,222 from 57 pharmaceutical and/or device companies across 482 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dakwar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in PA
$34,222 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,689
Medicare services
Top 1% in PA for urology physician
3,547
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~760 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 7,560 | $18 | $37 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,083 | $2 | $12 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,048 | $8 | $121 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
977 | $93 | $285 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
678 | $8 | $12 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 386 | $134 | $832 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
326 | $68 | $212 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
293 | $50 | $143 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
226 | $10 | $189 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
192 | $64 | $416 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
148 | $0 | $12 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
137 | $27 | $104 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
85 | $11 | $71 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $123 | $361 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
64 | $107 | $324 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
59 | $137 | $381 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
57 | $54 | $185 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
56 | $65 | $165 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
27 | $92 | $1,539 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
25 | $20 | $243 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
21 | $52 | $182 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
18 | $63 | $1,211 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $47 | $139 |
| Insertion of temporary bladder tube | 15 | $37 | $147 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $106 | $529 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
14 | $26 | $445 |
| Injection, garamycin, gentamicin, up to 80 mg | 14 | $2 | $25 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
13 | $123 | $565 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
13 | $570 | $4,886 |
| Complicated insertion of bladder tube | 12 | $63 | $368 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
12 | $598 | $2,179 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
11 | $27 | $456 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
11 | $163 | $530 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
66.6% medium
33.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$34,222
Total received (2018-2024)
Avg $4,889/year across 7 years
Top 5% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
482
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$21,129 (61.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,659 (37.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$433 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,729
2023
$1,913
2022
$1,772
2021
$1,221
2020
$691
2019
$22,371
2018
$1,526
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,871
Astellas Pharma US Inc
$495
Janssen Biotech, Inc.
$339
Bayer Healthcare Pharmaceuticals Inc.
$281
Dendreon Pharmaceuticals LLC
$262
Axonics, Inc.
$200
PFIZER INC.
$171
ABBVIE INC.
$159
Ferring Pharmaceuticals Inc.
$146
Janssen Scientific Affairs, LLC
$143
Sumitomo Pharma America, Inc.
$141
Tolmar, Inc.
$97
AstraZeneca Pharmaceuticals LP
$89
Merck Sharp & Dohme LLC
$72
PROGENICS PHARMACEUTICALS, INC.
$49
Telix Pharmaceuticals
$47
Novartis Pharmaceuticals Corporation
$39
Ambu Inc.
$35
BIOPROTECT MEDICAL, INC.
$21
Amgen Inc.
$21
Medtronic, Inc.
$18
PROCEPT BioRobotics Corporation
$17
Myriad Genetic Laboratories, Inc.
$16
Top 3 companies account for 57.2% of 2024 payments
All-time payments by company (2018-2024) ›
Covidien LP
$17,431
Janssen Biotech, Inc.
$4,941
Boston Scientific Corporation
$1,962
Dendreon Pharmaceuticals LLC
$984
Astellas Pharma US Inc
$962
PFIZER INC.
$893
Bayer HealthCare Pharmaceuticals Inc.
$617
Bayer Healthcare Pharmaceuticals Inc.
$549
Janssen Scientific Affairs, LLC
$515
Axonics, Inc.
$410
Ferring Pharmaceuticals Inc.
$375
AstraZeneca Pharmaceuticals LP
$355
Myovant Sciences Inc.
$352
Merck Sharp & Dohme LLC
$265
Teleflex LLC
$257
Intuitive Surgical, Inc.
$234
ABBVIE INC.
$232
Sumitomo Pharma America, Inc.
$224
Verity Pharmaceuticals Inc.
$204
Amgen Inc.
$201
Myriad Genetic Laboratories, Inc.
$189
Tolmar, Inc.
$189
Merck Sharp & Dohme Corporation
$179
E.R. Squibb & Sons, L.L.C.
$169
Endo Pharmaceuticals Inc.
$144
AbbVie Inc.
$130
Avadel Specialty Pharmaceuticals, LLC
$113
Blue Earth Diagnostics Limited
$113
Janssen Products, LP
$85
Telix Pharmaceuticals
$84
AbbVie, Inc.
$80
MEDIVATION FIELD SOLUTIONS LLC
$68
Novartis Pharmaceuticals Corporation
$56
Clinigen Inc
$56
UROVANT SCIENCES INC
$53
PROGENICS PHARMACEUTICALS, INC.
$49
UROGEN PHARMA, INC.
$43
Janssen Pharmaceuticals, Inc
$41
DENTSPLY IH AB
$37
C. R. BARD, INC. & SUBSIDIARIES
$36
Coloplast Corp
$35
Ambu Inc.
$35
BOSTON SCIENTIFIC CORPORATION
$30
C. R. Bard, Inc. & Subsidiaries
$27
Allergan, Inc.
$25
ACCORD HEALTHCARE, INC.
$22
BIOPROTECT MEDICAL, INC.
$21
Allergan Inc.
$18
Medtronic, Inc.
$18
PROCEPT BioRobotics Corporation
$17
Baxter Healthcare
$16
TESARO, Inc.
$16
Celgene Corporation
$15
Prometheus Laboratories Inc.
$13
Clovis Oncology, Inc.
$13
Foundation Medicine, Inc.
$12
Ipsen Biopharmaceuticals, Inc
$12
Top 3 companies account for 71.1% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AKEEGA · AQUABEAM SYSTEM · Abraxane · Androgel · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis CDx · Balversa · CAMCEVI · DARZALEX · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL ONCOLOGY · General - Kidney Stone Disease · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LILETTA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MYRBETRIQ · MYRISK · Myrbetriq · Noctiva · Nubeqa · OPDIVO · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Proleukin · Prolia · Rezum Generator · Rubraca · SURESTEP · SpaceOAR VUE System - 10mL · SpeediCath · TISSEEL · TOVIAZ · Titan · Trelstar · UROLIFT · UroLift System · Veozah · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · ZEJULA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (62%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for urology physician in PA.
Geographic Context
Urology physicians within 10 mi
297
Per 100K population
51.5
County median income
$88,576
Nearest hospital
RIDDLE MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dakwar is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with consulting-driven industry engagement in the top 5% of PA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dakwar experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Dakwar performed 7,560 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dakwar receive payments from pharmaceutical companies?
Yes. Dr. Dakwar received a total of $34,222 from 57 companies across 482 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dakwar's costs compare to other urology physicians in Media?
Dr. Dakwar's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dakwar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Media
Browse urology physicians in Media ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Covidien LP Payments to Doctors
See all physicians who received payments from Covidien LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology